Joshua D Rosenblat Selected Research

Joshua D Rosenblat Research Topics

Disease

46	Treatment-Resistant Depressive Disorder 04/2024 - 01/2019
44	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 09/2013
35	Bipolar Disorder (Manic Depressive Psychosis) 10/2023 - 08/2014
23	Mood Disorders (Mood Disorder) 04/2024 - 08/2014
13	Inflammation (Inflammations) 04/2024 - 05/2016
11	Cognitive Dysfunction 04/2024 - 01/2014
9	Anhedonia 02/2023 - 05/2016
9	Mental Disorders (Mental Disorder) 01/2023 - 06/2017
6	Schizophrenia (Dementia Praecox) 01/2022 - 08/2018
4	Headache (Headaches) 01/2024 - 01/2021
4	Nausea 01/2024 - 01/2021
4	Substance-Related Disorders (Drug Abuse) 08/2023 - 01/2022
4	Depressive Disorder (Melancholia) 01/2023 - 01/2019
4	COVID-19 01/2022 - 01/2020
4	Mania (Manias) 12/2020 - 04/2017
3	Postpartum Depression (Post-Natal Depression) 01/2024 - 11/2022
3	Neoplasms (Cancer) 01/2023 - 01/2018
3	Insulin Resistance 01/2023 - 01/2021
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2019
3	Hypertension (High Blood Pressure) 11/2021 - 01/2020
3	Obesity 01/2020 - 01/2019
2	Fatigue 02/2024 - 01/2023
2	Weight Gain 01/2024 - 01/2022
2	Neurobehavioral Manifestations 10/2022 - 01/2019
2	Psychomotor Agitation (Akathisia) 01/2022 - 01/2022
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2018
2	Neuroinflammatory Diseases 01/2020 - 11/2018
2	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 10/2018
1	Dizziness (Lightheadedness) 01/2024
1	Dysgeusia (Parageusia) 01/2023
1	Vomiting 01/2023
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2022
1	Metabolic Bone Diseases (Osteopenia) 12/2022
1	Death (Near-Death Experience) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Perceptual Disorders (Hemispatial Neglect) 06/2022
1	Hallucinations (Hallucination) 06/2022
1	Infections 01/2022
1	Obstructive Sleep Apnea 01/2022
1	Tardive Dyskinesia 12/2021
1	Pain (Aches) 11/2021

Drug/Important Bio-Agent (IBA)

58	Ketamine FDA LinkGeneric 04/2024 - 02/2016
44	Antidepressive Agents (Antidepressants)IBA 01/2024 - 07/2015
14	EsketamineIBA 04/2024 - 01/2020
10	Psilocybin (Psilocibin)IBA 04/2024 - 01/2021
8	VortioxetineIBA 04/2024 - 11/2019
8	Infliximab (Remicade)FDA Link 11/2022 - 01/2019
7	Hallucinogens (Psychedelics)IBA 04/2024 - 01/2021
6	CytokinesIBA 01/2022 - 08/2014
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2018
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 04/2017
5	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2019 - 08/2014
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 01/2018
4	Glutamic Acid (Glutamate)FDA Link 09/2023 - 01/2018
4	Therapeutic UsesIBA 11/2022 - 01/2020
3	C-Reactive ProteinIBA 04/2024 - 12/2015
3	Lysergic Acid Diethylamide (LSD)IBA 04/2024 - 01/2021
3	zuranoloneIBA 01/2024 - 11/2019
3	LithiumIBA 01/2024 - 12/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2020
3	Insulin (Novolin)FDA Link 01/2021 - 01/2014
2	Tuberculin (PPD)IBA 01/2024 - 11/2022
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2024 - 11/2021
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2023 - 01/2019
2	Escitalopram FDA Link 01/2023 - 01/2019
2	VaccinesIBA 01/2023 - 01/2022
2	3-carboxamido-4-hydroxynaltrexoneIBA 01/2022 - 04/2018
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 12/2020
2	Anesthetics (Anesthetic Agents)IBA 11/2021 - 04/2021
2	LeptinIBA 10/2020 - 01/2020
2	Minocycline (Cyclops)FDA LinkGeneric 10/2019 - 08/2014
2	gamma-Aminobutyric Acid (GABA)IBA 11/2018 - 08/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2018 - 09/2013
2	KynurenineIBA 08/2018 - 01/2017
2	Glutamine (L-Glutamine)FDA Link 08/2018 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 08/2018 - 01/2017
2	sapropterin (tetrahydrobiopterin)FDA Link 01/2017 - 05/2016
1	cariprazineIBA 04/2024
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2024
1	Phosphorus (Red Phosphorus)IBA 12/2022
1	MineralsIBA 12/2022
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	ProlactinIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	lumateperoneIBA 01/2022
1	Trace amine-associated receptor 1IBA 12/2021
1	SEP-363856IBA 12/2021
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2021
1	PlacebosIBA 10/2021

Therapy/Procedure

9	Therapeutics 03/2024 - 08/2014
4	Drug Therapy (Chemotherapy) 04/2023 - 01/2019
1	Investigational Therapies (Experimental Therapy) 01/2024
1	Palliative Care (Palliative Therapy) 01/2023
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2023
1	Pain Management 11/2021
1	Anesthesia 11/2021